台股 » 個股 » 生華科 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生華科

(6492)
可現股當沖
  • 股價
    50.5
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    713
  • 產業
    上櫃 生技醫療類股
  • 154人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
生華科 (6492)籌碼相關-富邦-三峽 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-三峽 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/10/28656.43455.8052.6027560.26%
2024/10/25153.8000.0054.4016450.15%
2024/09/26152.3000.0051.9011,0230.10%
2024/09/23255.7000.0054.6021,0190.20%
2024/09/19156.20355.0053.20-2995-0.20%
2024/09/04148.8000.0047.8511,0170.10%
2024/09/0300.00351.4351.40-31,007-0.30%
2024/09/02351.0000.0050.7031,0030.30%
2024/08/2200.00950.0949.80-9962-0.94%
2024/08/1600.00450.3550.10-4928-0.43%
2024/08/1200.00149.0048.15-1885-0.11%
2024/08/09149.0000.0048.1518790.11%
2024/08/0800.00149.2549.75-1865-0.12%
2024/08/061449.1800.0049.00148411.66%
2024/08/0200.00254.3053.00-2809-0.25%
2024/07/29156.0000.0056.9017880.13%
2024/07/2200.00158.5056.20-1752-0.13%
2024/07/19258.00158.9058.1017350.14%
2024/07/1700.00159.6058.90-1543-0.18%
2024/07/16157.00156.6057.2004270.00%
2024/07/01147.7500.0047.1013020.33%
2024/06/12241.8000.0041.8021521.31%
2023/12/29151.0000.0050.9011,3080.08%
2023/12/26152.7000.0051.8011,3030.08%
2023/11/2700.003156.7255.20-311,119-2.77%
2023/11/2400.00955.2354.30-91,097-0.82%
2023/11/232055.3800.0055.40201,0991.82%
2023/11/2000.00154.9055.10-11,070-0.09%
2023/11/162154.9200.0054.60211,0531.99%
2023/11/1000.00156.6054.10-11,010-0.10%
2023/11/09254.45253.3053.4009480.00%
2023/11/0600.00158.8057.40-1861-0.12%
2023/11/03259.85161.1059.4018120.12%
2023/11/02158.60359.5059.10-2744-0.27%
2023/11/012361.205360.5560.40-30690-4.34%
2023/10/313358.6100.0058.80335066.52%
2023/10/30355.80655.6254.50-3369-0.81%
2023/10/2700.00954.4054.40-9240-3.74%
2023/10/26349.3800.0049.5031831.64%
2023/09/07046.30245.8345.50-2160-1.24%
2023/08/30244.1000.0044.5021411.41%
2023/07/2700.00645.2345.20-6122-4.88%
2023/07/17646.0000.0045.8061304.59%
2023/07/1300.00347.5047.80-3125-2.39%
2023/07/031250.4700.0050.10121299.27%
2023/06/2900.00150.7051.10-1129-0.77%
2023/06/28150.0000.0050.7011280.78%
生華科新藥再獲孤兒藥資格 上市可獲7年市場獨賣保護期Anue鉅亨-6天前
上櫃「肥貓」董監現形 台嘉碩、大宇資、穩懋、生華科為前四肥Anue鉅亨-2024/04/15
生華科治療新冠、流感等泛病毒感染新藥 將啟動二期臨床Anue鉅亨-2023/11/21
生華科 相關文章
生華科 相關影音